All News Top News Oct 7, 2019 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 Learn More Share Top News Oct 2, 2019 Teva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at Psych Congress 2019 Learn More Share Top News Oct 2, 2019 Teva Announces Leadership Change in its Global Operations Group Learn More Share Top News Sep 4, 2019 Teva to Present New Analyses of Fremanezumab Efficacy and Safety in Adult Patients with Difficult-to-Treat Migraine at 19th Congress of the International Headache Society Learn More Share Top News Sep 3, 2019 Teva Announces United States Department of Commerce Appointment of Brendan O’Grady to Investment Advisory Council Learn More Share
Top News Oct 7, 2019 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 Learn More
Top News Oct 2, 2019 Teva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at Psych Congress 2019 Learn More
Top News Sep 4, 2019 Teva to Present New Analyses of Fremanezumab Efficacy and Safety in Adult Patients with Difficult-to-Treat Migraine at 19th Congress of the International Headache Society Learn More
Top News Sep 3, 2019 Teva Announces United States Department of Commerce Appointment of Brendan O’Grady to Investment Advisory Council Learn More